HCM Q2 2025 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$139M-9.2% YoY

Gross Profit

$55M39.7% margin

Operating Income

-$2M-1.3% margin

Net Income

$227M163.8% margin

EPS (Diluted)

$1.30

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$41M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$534M

Stockholders' Equity

$1.2B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$153M	-9.2%
Gross Profit	$55M	$63M	-12.3%
Operating Income	-$2M	-$14M	+87.2%
Net Income	$227M	$13M	+1663.3%